Back to Results
First PageMeta Content
Alcohols / Euphoriants / Phenols / Ketones / Buprenorphine / Methadone / Naloxone / Opioid dependence / Opioid / Chemistry / Organic chemistry / Morphinans


HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BUNAVAIL safely and effectively. See full prescribing information for BUNAVAIL. 
Add to Reading List

Document Date: 2014-10-14 11:58:22


Open Document

File Size: 290,66 KB

Share Result on Facebook

Event

Product Issues / Product Recall / /

Facility

Store BUNAVAIL / /

IndustryTerm

buprenorphine sublingual solutions / machinery / food / hazardous machinery / buprenorphine products / fixed-dose combination product / combination product / fixed combination product / buprenorphine product / /

MedicalCondition

anaphylactic shock / myoclonus / headache / CNS Depression / neonatal withdrawal syndrome / hives / cytolytic hepatitis / coma / dysfunction / apnea / respiratory depression / nausea / prostatic hypertrophy / hepatitis C / hepatitis B / hyperhidrosis / hepatic necrosis / withdrawal syndrome / bradycardia / Hypersensitivity / Hepatitis / constipation / pruritus / hepatorenal syndrome / head injury / insomnia / toxic psychoses / bronchospasm / urethral stricture / hypothyroidism / Carcinogenesis / chronic obstructive pulmonary disease / acute hepatitis / hepatic encephalopathy / increased CNS depression / chronic administration / Orthostatic Hypotension / Addison’s disease / vomiting / pain / hypertonia / neonatal tremor / fatal / respiratory depression / acute alcoholism / myxedema / hepatic failure / Allergic Reactions / Drug Abuse / Significant respiratory depression / Respiratory Depression / infection / delirium tremens / opioid withdrawal syndrome / miosis / angioneurotic edema / cor pulmonale / /

MedicalTreatment

counseling / psychotherapy / pharmacotherapy / /

Movie

CIII Initial U.S / /

Organization

Chronic administration / _______________DOSAGE AND ADMINISTRATION / FDA / /

/

Position

Secretary of Health / physician / General / /

Product

Neonatal Withdrawal Neonatal / signs / Neonatal / Sublingual Tablet / Sublingual Tablets / Use / naloxone / SUBOXONE / Opioid / syndrome / Hepatic Function Impairment / machinery / /

Technology

drug screening / Pharmacokinetics / Pharmacodynamics / /

URL

www.fda.gov/medwatch / /

SocialTag